SIR2: The Biochemical Mechanism of NAD+-Dependent Protein Deacetylation and ADP-Ribosyl Enzyme Intermediates

E-ISSN： 1875-533x|11|7|807-826

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.7, 2004-04, pp. : 807-826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 279-291

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases

Current Drug Targets, Vol. 13, Iss. 2, 2012-02 ,pp. : 222-229

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2117-2130

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+/NADH Metabolism and NAD+-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-01 ,pp. : 1239-1247

Bentham Science Publishers

Access to resources Recommend Favorite